reference/17973139

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17973139

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	86
issn	0090-4295
pageRange	79-86
publicationName	Urology
startingPage	79
bibliographicCitation	Hellerstedt B. Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer. Urology. 2003 Dec 29;62 Suppl 1():79–86. doi: 10.1016/j.urology.2003.09.002. PMID: 14747045.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e49ff521fed8405a1df53d2977314a8
date	2003-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/14747045 https://doi.org/10.1016/j.urology.2003.09.002
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7907 https://portal.issn.org/resource/ISSN/0090-4295
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer
discusses	http://id.nlm.nih.gov/mesh/M0001103 http://id.nlm.nih.gov/mesh/M0001106 http://id.nlm.nih.gov/mesh/M0151653 http://id.nlm.nih.gov/mesh/M0007520 http://id.nlm.nih.gov/mesh/M0012446 http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0027324 http://id.nlm.nih.gov/mesh/M0028300 http://id.nlm.nih.gov/mesh/M0026444 http://id.nlm.nih.gov/mesh/M0006357 http://id.nlm.nih.gov/mesh/M0021712 http://id.nlm.nih.gov/mesh/M0001214 http://id.nlm.nih.gov/mesh/M0014878
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009363Q000097 http://id.nlm.nih.gov/mesh/D000726Q000627 http://id.nlm.nih.gov/mesh/D007987Q000819 http://id.nlm.nih.gov/mesh/D017430Q000097 http://id.nlm.nih.gov/mesh/D018931Q000627 http://id.nlm.nih.gov/mesh/D000230Q000188 http://id.nlm.nih.gov/mesh/D016879 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D009376Q000188 http://id.nlm.nih.gov/mesh/D000728
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007987Q000037 http://id.nlm.nih.gov/mesh/D011471Q000601 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D009919 http://id.nlm.nih.gov/mesh/D000726Q000009 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000813Q000627 http://id.nlm.nih.gov/mesh/D018931Q000009 http://id.nlm.nih.gov/mesh/D014105 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D000230Q000532 http://id.nlm.nih.gov/mesh/D009376Q000601 http://id.nlm.nih.gov/mesh/D009364Q000097 http://id.nlm.nih.gov/mesh/D000230Q000601 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D009570 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004054Q000627 http://id.nlm.nih.gov/mesh/D004791Q000627 http://id.nlm.nih.gov/mesh/D011468 http://id.nlm.nih.gov/mesh/D011471Q000532 http://id.nlm.nih.gov/mesh/D009376Q000532 http://id.nlm.nih.gov/mesh/D018120Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fce276cc0efd2412c7dafdbb1e82fcc8

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129125890 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128501763 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129153627 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127709388

Total number of triples: 76.